Drug Shortage Report for POTASSIUM PHOSPHATE MONOBASIC INJECTION
| Report ID | 178565 |
| Drug Identification Number | 00711306 |
| Brand name | PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML |
| Common or Proper name | PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM PHOSPHATE MONOBASIC |
| Strength(s) | 176MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10ML |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-07 |
| Estimated end date | 2023-03-31 |
| Actual end date | 2023-04-06 |
| Shortage status | Resolved |
| Updated date | 2023-04-07 |
| Company comments | Baxter item 6720. Product is available on allocation based on 90% of historical volumes. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2023-04-07 | English | Compare |
| v9 | 2023-04-06 | French | Compare |
| v8 | 2023-04-06 | English | Compare |
| v7 | 2023-02-14 | French | Compare |
| v6 | 2023-02-14 | English | Compare |
| v5 | 2022-12-16 | French | Compare |
| v4 | 2022-12-16 | English | Compare |
| v3 | 2022-12-15 | French | Compare |
| v2 | 2022-12-15 | English | Compare |
| v1 | 2022-12-15 | English | Compare |
Showing 1 to 10 of 10